Dr. Gina Agiostratidou is the Program Director for the Helmsley Charitable Trust’s Type 1 Diabetes (T1D) Program as well as its New York City (NYC) program. Through Gina’s leadership, the T1D program supports the global T1D community to live safer, better, and more fulfilling lives today while funding advancements in research and technology for a better tomorrow. Helmsley’s NYC program is focused on finding and fixing the roadblocks standing between vulnerable people and the path to a healthier life. Both programs are dedicated to understanding what people living with challenging health conditions need to thrive, and then supporting novel approaches to making that possible.
Prior to joining Helmsley, Gina was the scientific program manager at the Children’s Tumor Foundation, bringing scientists from around the globe together to collaborate on research opportunities in the field of neurofibromatosis. She completed two post-doctoral fellowships at Albert Einstein College of Medicine and Mount Sinai School of Medicine, focusing primarily on molecular biology and biochemistry.
Gina earned a Ph.D. in molecular biology from the Medical School, National and Capodistrian University of Athens, Greece, and a M.Sc. degree in advanced molecular biology and biotechnology at the University of London, UK. Recognizing the benefits of management training and a business acumen within philanthropy, she earned an M.B.A. from New York University’s Stern Business School since joining Helmsley in 2010.
- Op-Ed: Lessons from Diabetes Can Strengthen Global Care for People with NCDs
- T1D Program Director Gina Agiostratidou, PhD Joins “Progress, Potential, and Possibilities” Podcast
- T1D Program Director Gina Agiostratidou, PhD Interviewed by Grantee INNODIA
- T1D Program Director Gina Agiostratidou Discusses NCD Care in Health Policy Watch
- Gina Agiostratidou, PhD Quoted in Coverage of the Lancet NCDI Poverty Commission
- Non-Communicable Diseases and Injuries: Closing the Gap for the Poorest Billion